H

Hikal Ltd

Pharmaceuticals

SMALLCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 1 analyst offering recommendations for Hikal Ltd

100%

Buy

0%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio69.9949.42
PB Ratio4.106.33
Dividend Yield0.30%0.53%

Understand what these metrics mean. 

About the company

H

Hikal Ltd

Hikal Limited is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharmaceutical ingredients and contract research activities. The Company offers pharmaceuticals and a...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions